| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.14 | 0.003 |